GET /trials/source/12/
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 380,
    "next": "http://api.gregory-ms.com/trials/source/12/?page=2",
    "previous": null,
    "results": [
        {
            "title": "Lifestyle Intervention for Patients With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Behavioral: Lifestyle intervention program \"Leef! met MS\"<br /><b>Sponsors</b>:    Amsterdam UMC, location VUmc;   National MS Foundation, The Netherlands;   Voeding Leeft<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05402501?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-06-02T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-06-02T14:30:06.868908Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Aerobic Exercise in Persons With Multiple Sclerosis With Restless Legs Syndrome",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Behavioral: Aerobic exercise<br /><b>Sponsor</b>:    Dokuz Eylul University<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05402956?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-06-02T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-06-02T14:30:06.875405Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Reinventing Yourself With Multiple Sclerosis (MS)",
            "summary": "&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Intervention&lt;&#x2F;b&gt;:    Behavioral: Reinvention with MS&lt;br&#x2F;&gt;&lt;b&gt;Sponsors&lt;&#x2F;b&gt;:    Kessler Foundation;   Craig Hospital;   University of Minnesota&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05195320?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
            "published_date": "2022-01-17T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-01-18T12:46:55Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "L Test in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Behavioral: L test<br /><b>Sponsor</b>:    Firat University<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05325359?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-04-13T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-04-13T11:59:18.442353Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: cytof analysis<br /><b>Sponsor</b>:    Rennes University Hospital<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05326048?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-04-13T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-04-13T11:59:18.443892Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Effects of Telerehabilitation-Based Motor Imagery Training on Pain in People With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Pain<br /><b>Intervention</b>:    Behavioral: Telerehabilitation-based motor imagery training<br /><b>Sponsors</b>:    Dokuz Eylul University;   Izmir Katip Celebi University<br /><b>Not yet recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05326711?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-04-13T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-04-13T11:59:18.445167Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "The Relationship of Neuropathic Pain With Incontinence, Disability and Life Quality in Multiple Sclerosis Patients",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Disabilities Multiple;   Quality of Life;   Incontinence, Urinary;   Incontinence Bowel;   Neuropathic Pain<br /><b>Intervention</b>:    Other: Neuropathic Pain<br /><b>Sponsor</b>:    Istanbul University-Cerrahpasa<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05374811?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-05-16T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-05-16T12:00:08.079361Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "A Phase I Study of LP-168 in Healthy Volunteers",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   NMO Spectrum Disorder<br /><b>Interventions</b>:    Drug: LP-168 tablet;   Drug: LP-168 Placebo tablet<br /><b>Sponsor</b>:    Guangzhou Lupeng Pharmaceutical Company LTD.<br /><b>Recruiting</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05432713?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-06-27T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-06-27T13:30:06.503597Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Therapeutic Effects of Line Dancing in People With MS",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br /><b>Intervention</b>:    Other: line dancing<br /><b>Sponsors</b>:    Gazi University;   Hacettepe University;   Fenerbahce University<br /><b>Completed</b>",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05322915?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "published_date": "2022-04-12T16:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-04-12T12:59:17.118072Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        },
        {
            "title": "Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf",
            "summary": "&lt;b&gt;Condition&lt;&#x2F;b&gt;:    Relapsing Multiple Sclerosis&lt;br&#x2F;&gt;&lt;b&gt;Interventions&lt;&#x2F;b&gt;:    Other: Ofatumumab;   Other: Ocrelizumab&lt;br&#x2F;&gt;&lt;b&gt;Sponsor&lt;&#x2F;b&gt;:    Novartis Pharmaceuticals&lt;br&#x2F;&gt;&lt;b&gt;Not yet recruiting&lt;&#x2F;b&gt;",
            "link": "https://clinicaltrials.gov/ct2/show/NCT05266469?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
            "published_date": "2022-03-04T17:00:00Z",
            "source": "Clinical Trials.gov",
            "publisher": null,
            "container_title": null,
            "relevant": null,
            "ml_prediction_gnb": null,
            "ml_prediction_lr": null,
            "discovery_date": "2022-03-04T17:22:45Z",
            "noun_phrases": null,
            "doi": null,
            "access": null,
            "takeaways": null
        }
    ]
}